These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24034697)

  • 1. Inactivation of the novel avian influenza A (H7N9) virus under physical conditions or chemical agents treatment.
    Zou S; Guo J; Gao R; Dong L; Zhou J; Zhang Y; Dong J; Bo H; Qin K; Shu Y
    Virol J; 2013 Sep; 10():289. PubMed ID: 24034697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avian influenza virus (H5N1); effects of physico-chemical factors on its survival.
    Shahid MA; Abubakar M; Hameed S; Hassan S
    Virol J; 2009 Mar; 6():38. PubMed ID: 19327163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation.
    Pawar SD; Murtadak VB; Kale SD; Shinde PV; Parkhi SS
    J Virol Methods; 2015 Sep; 222():28-33. PubMed ID: 25997377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inactivation of avian influenza virus subtype H5N1 isolated from chickens in Thailand by chemical and physical treatments.
    Wanaratana S; Tantilertcharoen R; Sasipreeyajan J; Pakpinyo S
    Vet Microbiol; 2010 Jan; 140(1-2):43-8. PubMed ID: 19632071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses.
    Jiang WM; Wang SC; Liu HL; Yu JM; Du X; Hou GY; Li JP; Liu S; Wang KC; Zhuang QY; Liu XM; Chen JM
    Vaccine; 2014 Nov; 32(48):6433-9. PubMed ID: 25285880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence and Adaptation of a Novel Highly Pathogenic H7N9 Influenza Virus in Birds and Humans from a 2013 Human-Infecting Low-Pathogenic Ancestor.
    Qi W; Jia W; Liu D; Li J; Bi Y; Xie S; Li B; Hu T; Du Y; Xing L; Zhang J; Zhang F; Wei X; Eden JS; Li H; Tian H; Li W; Su G; Lao G; Xu C; Xu B; Liu W; Zhang G; Ren T; Holmes EC; Cui J; Shi W; Gao GF; Liao M
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29070694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.
    Tang J; Zhang J; Zhou J; Zhu W; Yang L; Zou S; Wei H; Xin L; Huang W; Li X; Cheng Y; Wang D
    Virol J; 2019 Jul; 16(1):87. PubMed ID: 31266524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple amino acid substitutions involved in the adaption of three avian-origin H7N9 influenza viruses in mice.
    Qin J; Peng O; Shen X; Gong L; Xue C; Cao Y
    Virol J; 2019 Jan; 16(1):3. PubMed ID: 30621708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human.
    Li J; Yu X; Pu X; Xie L; Sun Y; Xiao H; Wang F; Din H; Wu Y; Liu D; Zhao G; Liu J; Pan J
    Sci China Life Sci; 2013 Jun; 56(6):485-92. PubMed ID: 23657795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathobiology of Tennessee 2017 H7N9 low and high pathogenicity avian influenza viruses in commercial broiler breeders and specific pathogen free layer chickens.
    Bertran K; Lee DH; Criado MF; Smith D; Swayne DE; Pantin-Jackwood MJ
    Vet Res; 2018 Aug; 49(1):82. PubMed ID: 30157963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmissibility of novel H7N9 and H9N2 avian influenza viruses between chickens and ferrets.
    Ku KB; Park EH; Yum J; Kim HM; Kang YM; Kim JC; Kim JA; Kim HS; Seo SH
    Virology; 2014 Feb; 450-451():316-23. PubMed ID: 24503095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of H7N9 influenza A viruses isolated from humans.
    Watanabe T; Kiso M; Fukuyama S; Nakajima N; Imai M; Yamada S; Murakami S; Yamayoshi S; Iwatsuki-Horimoto K; Sakoda Y; Takashita E; McBride R; Noda T; Hatta M; Imai H; Zhao D; Kishida N; Shirakura M; de Vries RP; Shichinohe S; Okamatsu M; Tamura T; Tomita Y; Fujimoto N; Goto K; Katsura H; Kawakami E; Ishikawa I; Watanabe S; Ito M; Sakai-Tagawa Y; Sugita Y; Uraki R; Yamaji R; Eisfeld AJ; Zhong G; Fan S; Ping J; Maher EA; Hanson A; Uchida Y; Saito T; Ozawa M; Neumann G; Kida H; Odagiri T; Paulson JC; Hasegawa H; Tashiro M; Kawaoka Y
    Nature; 2013 Sep; 501(7468):551-5. PubMed ID: 23842494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
    Barman S; Krylov PS; Turner JC; Franks J; Webster RG; Husain M; Webby RJ
    Vaccine; 2017 Mar; 35(10):1424-1430. PubMed ID: 28162820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of route of exposure and challenge dose on the pathogenesis of H7N9 low pathogenicity avian influenza virus in chickens.
    Spackman E; Pantin-Jackwood M; Swayne DE; Suarez DL; Kapczynski DR
    Virology; 2015 Mar; 477():72-81. PubMed ID: 25662310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
    Nakamura K; Shirakura M; Suzuki Y; Naito T; Fujisaki S; Tashiro M; Nobusawa E
    Vaccine; 2016 Jan; 34(3):328-33. PubMed ID: 26657023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
    Riegger D; Hai R; Dornfeld D; Mänz B; Leyva-Grado V; Sánchez-Aparicio MT; Albrecht RA; Palese P; Haller O; Schwemmle M; García-Sastre A; Kochs G; Schmolke M
    J Virol; 2015 Feb; 89(4):2241-52. PubMed ID: 25505067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population.
    Yen HL; McKimm-Breschkin JL; Choy KT; Wong DD; Cheung PP; Zhou J; Ng IH; Zhu H; Webby RJ; Guan Y; Webster RG; Peiris JS
    mBio; 2013 Jul; 4(4):. PubMed ID: 23860768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenicity of two novel human-origin H7N9 highly pathogenic avian influenza viruses in chickens and ducks.
    Tanikawa T; Uchida Y; Takemae N; Tsunekuni R; Mine J; Liu MT; Yang JR; Shirakura M; Watanabe S; Odagiri T; Saito T
    Arch Virol; 2019 Feb; 164(2):535-545. PubMed ID: 30539262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of novel reassortant avian influenza H7N9 virus infection in vitro with three antiviral drugs, oseltamivir, peramivir and favipiravir.
    Cao RY; Xiao JH; Cao B; Li S; Kumaki Y; Zhong W
    Antivir Chem Chemother; 2014 Dec; 23(6):237-40. PubMed ID: 23948557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H7N9 avian influenza A virus in China: a short report on its circulation, drug resistant mutants and novel antiviral drugs.
    Danqi B; Li Z; Liu Q; Richt JA
    Expert Rev Anti Infect Ther; 2017 Aug; 15(8):723-727. PubMed ID: 28692316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.